$NVEC
NVE CORP /NEW/

2018 Q3 Form 10-Q Financial Statement

#000143774918018287 Filed on October 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $7.506M $6.996M
YoY Change 7.29% -4.19%
Cost Of Revenue $1.353M $1.353M
YoY Change -0.02% -22.27%
Gross Profit $6.153M $5.643M
YoY Change 9.04% 1.46%
Gross Profit Margin 81.98% 80.66%
Selling, General & Admin $377.4K $348.4K
YoY Change 8.35% 1.36%
% of Gross Profit 6.13% 6.17%
Research & Development $972.0K $1.031M
YoY Change -5.68% 34.15%
% of Gross Profit 15.8% 18.26%
Depreciation & Amortization $180.0K $240.0K
YoY Change -25.0% 20.0%
% of Gross Profit 2.93% 4.25%
Operating Expenses $1.349M $1.379M
YoY Change -2.14% 24.01%
Operating Profit $4.804M $4.264M
YoY Change 12.65% -4.17%
Interest Expense $440.0K $390.0K
YoY Change 12.82% -9.3%
% of Operating Profit 9.16% 9.15%
Other Income/Expense, Net
YoY Change
Pretax Income $5.247M $4.652M
YoY Change 12.79% -4.69%
Income Tax $964.5K $1.491M
% Of Pretax Income 18.38% 32.05%
Net Earnings $4.283M $3.161M
YoY Change 35.48% -4.36%
Net Earnings / Revenue 57.06% 45.18%
Basic Earnings Per Share $0.88 $0.65
Diluted Earnings Per Share $0.88 $0.65
COMMON SHARES
Basic Shares Outstanding 4.843M 4.841M
Diluted Shares Outstanding 4.853M 4.846M

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.00M $22.00M
YoY Change 36.36% -21.43%
Cash & Equivalents $6.048M $5.108M
Short-Term Investments $23.90M $16.90M
Other Short-Term Assets $700.0K $500.0K
YoY Change 40.0% -28.57%
Inventory $3.576M $3.504M
Prepaid Expenses
Receivables $3.045M $2.660M
Other Receivables $0.00 $0.00
Total Short-Term Assets $37.26M $28.72M
YoY Change 29.75% -17.91%
LONG-TERM ASSETS
Property, Plant & Equipment $1.117M $1.623M
YoY Change -31.21% 11.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $46.90M $59.60M
YoY Change -21.31% -1.97%
Other Assets $600.0K $400.0K
YoY Change 50.0% 300.0%
Total Long-Term Assets $48.60M $61.68M
YoY Change -21.2% -1.08%
TOTAL ASSETS
Total Short-Term Assets $37.26M $28.72M
Total Long-Term Assets $48.60M $61.68M
Total Assets $85.86M $90.40M
YoY Change -5.01% -7.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $253.7K $249.7K
YoY Change 1.6% -19.46%
Accrued Expenses $500.0K $600.0K
YoY Change -16.67% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $716.0K $830.5K
YoY Change -13.79% -33.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $716.0K $830.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $700.0K $800.0K
YoY Change -12.5% -38.46%
SHAREHOLDERS EQUITY
Retained Earnings $66.31M $69.94M
YoY Change -5.18% -8.37%
Common Stock $19.87M $19.60M
YoY Change 1.37% 1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $85.15M $89.56M
YoY Change
Total Liabilities & Shareholders Equity $85.86M $90.40M
YoY Change -5.01% -7.13%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income $4.283M $3.161M
YoY Change 35.48% -4.36%
Depreciation, Depletion And Amortization $180.0K $240.0K
YoY Change -25.0% 20.0%
Cash From Operating Activities $3.620M $2.100M
YoY Change 72.38% 41.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$140.0K
YoY Change -100.0% -6.67%
Acquisitions
YoY Change
Other Investing Activities -$1.310M $3.610M
YoY Change -136.29% -50.21%
Cash From Investing Activities -$1.310M $3.470M
YoY Change -137.75% -51.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.720M -4.840M
YoY Change -2.48% 1.04%
NET CHANGE
Cash From Operating Activities 3.620M 2.100M
Cash From Investing Activities -1.310M 3.470M
Cash From Financing Activities -4.720M -4.840M
Net Change In Cash -2.410M 730.0K
YoY Change -430.14% -80.74%
FREE CASH FLOW
Cash From Operating Activities $3.620M $2.100M
Capital Expenditures $0.00 -$140.0K
Free Cash Flow $3.620M $2.240M
YoY Change 61.61% 37.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q3 nvec Available For Sale Debt Securitites Percent Of Total Assets
AvailableForSaleDebtSecurititesPercentOfTotalAssets
0.89
CY2018Q3 nvec Debt Securities Available For Sale Securities Maturity Allocated And Single Maturity Date Three Through Five Years Fair Value
DebtSecuritiesAvailableForSaleSecuritiesMaturityAllocatedAndSingleMaturityDateThreeThroughFiveYearsFairValue
24075917
CY2018Q3 nvec Debt Securities Available For Sale Securitiest Maturity Allocated And Signle Maturity Date One Through Three Years Fair Value
DebtSecuritiesAvailableForSaleSecuritiestMaturityAllocatedAndSignleMaturityDateOneThroughThreeYearsFairValue
22784235
CY2018Q3 nvec Number Of Other Than Temporarily Impaired Available Forsale Securities
NumberOfOtherThanTemporarilyImpairedAvailableForsaleSecurities
0
CY2018Q3 nvec Number Of Other Than Temporarily Impaired Marketable Securities
NumberOfOtherThanTemporarilyImpairedMarketableSecurities
0
CY2017Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
253702
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
414970
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045230
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2888779
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10066677
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9819888
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1031790
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-915635
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19817088
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19599298
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93360
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93360
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40920
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40920
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15000
CY2018Q3 us-gaap Assets
Assets
85863363
CY2018Q1 us-gaap Assets
Assets
87431465
CY2018Q3 us-gaap Assets Current
AssetsCurrent
37261608
CY2018Q1 us-gaap Assets Current
AssetsCurrent
32695269
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2018Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1320776
CY2018Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1249360
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
77897062
CY2018Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
78804359
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
29716134
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
76576286
CY2018Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
77554999
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6047918
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4755082
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8199364
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5108313
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1292836
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3091051
CY2018Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4844010
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4842010
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4844010
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4842010
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
48440
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
48420
CY2018Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4333847
CY2017Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3173773
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8171869
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
6526415
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
1352845
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
1353169
us-gaap Cost Of Revenue
CostOfRevenue
2748850
us-gaap Cost Of Revenue
CostOfRevenue
3151535
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
22873364
CY2018Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
9072719
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
740192
CY2018Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
245511
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
47928537
CY2018Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
61731248
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
580584
CY2018Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1003849
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
70801901
CY2018Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
70803967
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1320776
CY2018Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1249360
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-36743
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-113718
CY2018Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
625024
CY2018Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
572655
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
357166
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
480143
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.33
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.33
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
462262
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
574755
CY2018Q3 us-gaap Gross Profit
GrossProfit
6153230
CY2017Q3 us-gaap Gross Profit
GrossProfit
5643065
us-gaap Gross Profit
GrossProfit
11865131
us-gaap Gross Profit
GrossProfit
11452365
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5247144
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4652058
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10066028
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9518050
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
964534
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1491023
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1838369
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3059400
us-gaap Income Taxes Paid
IncomeTaxesPaid
1866045
us-gaap Income Taxes Paid
IncomeTaxesPaid
2975019
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-273761
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-122053
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156451
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-777184
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-142733
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-74476
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
146180
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15588
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-84093
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9612
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4622
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8548
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4897
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
600937
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
737917
CY2018Q3 us-gaap Inventory Net
InventoryNet
3575963
CY2018Q1 us-gaap Inventory Net
InventoryNet
3650439
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1103638
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1084030
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1871388
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1828492
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
443325
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
387860
us-gaap Investment Income Interest
InvestmentIncomeInterest
868095
us-gaap Investment Income Interest
InvestmentIncomeInterest
749638
CY2018Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1787269
CY2018Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1749284
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
85863363
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87431465
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
715964
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
989725
CY2018Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9395987
CY2018Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9395987
CY2018Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
23941749
CY2018Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
20765809
CY2018Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
46860152
CY2018Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
52838158
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9559570
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9682020
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2582288
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-725337
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8270118
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7316306
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
4282610
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
3161035
us-gaap Net Income Loss
NetIncomeLoss
8227659
us-gaap Net Income Loss
NetIncomeLoss
6458650
us-gaap Open Tax Year
OpenTaxYear
1999 2014 2015 2016 2017
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
1349411
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
1378867
us-gaap Operating Expenses
OperatingExpenses
2667198
us-gaap Operating Expenses
OperatingExpenses
2683953
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4803819
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4264198
us-gaap Operating Income Loss
OperatingIncomeLoss
9197933
us-gaap Operating Income Loss
OperatingIncomeLoss
8768412
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
51237
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12738
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-55790
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
67765
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9684020
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9682020
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6679727
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12138960
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37985
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
526377
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
650748
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
635160
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
124450
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9300000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11940000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11183256
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11145271
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1116579
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1325383
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
971963
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1030504
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1960989
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1936229
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
66313661
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
67709657
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Significant Accounting Policies</div><br /> <div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div><br /> &nbsp;&nbsp;&nbsp;&nbsp;We recognize revenue when we satisfy performance obligations by the transfer of control of products or services to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those products or services. Revenue is disaggregated into product sales and contract research and development to depict the nature, amount, timing of revenue recognition and economic characteristics of our business, and is represented within the financial statements.<br /> <br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize revenue from product sales to customers and distributors when we satisfy our performance obligation, at a point in time, upon product shipment or delivery to our customer or distributor as determined by agreed upon shipping terms. Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expenses. Under certain limited circumstances, our distributors <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties. We recognize any such commissions as selling, general, and administrative expenses. We recognize discounts provided to our distributors as reductions in revenue.<br /> <br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize contract research and development revenue over a period of time as the performance obligation is satisfied over a period of time rather than a point in time. Contracts have specifications unique to each customer and do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> create an asset with an alternate use, and we have an enforceable right to payment for performance completed to date. We recognize revenue over a period of time using costs incurred as the measurement of progress towards completion.<br /> <br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable is recognized when we have transferred a good or service to a customer and our right to receive consideration is unconditional through the completion of our performance obligation. A contract asset is recognized when we have a right to consideration from the transfer of goods or services to a customer but have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> completed our performance obligation. A contract liability is recognized when we have been paid by a customer but have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet satisfied the performance obligation by transferring goods or services. We had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> material contract assets or contract liabilities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div><br /> <br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our performance obligations related to product sales and contract research and development contracts are satisfied in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. Unsatisfied performance obligations represent contracts with an original expected duration of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less. As permitted under Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div>, we are using the practical expedient <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to disclose the value of these unsatisfied performance obligations. We also use the practical expedient in which we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year or less.</div></div></div>
CY2018Q3 us-gaap Revenues
Revenues
7506075
CY2017Q3 us-gaap Revenues
Revenues
6996234
us-gaap Revenues
Revenues
14613981
us-gaap Revenues
Revenues
14603900
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
377448
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
348363
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
706209
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
747724
us-gaap Share Based Compensation
ShareBasedCompensation
93360
us-gaap Share Based Compensation
ShareBasedCompensation
40920
CY2018Q3 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
85147399
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
86441740
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2018Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4852644
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4845632
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4851072
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4845907
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4843032
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4841010
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4842524
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4841010

Files In Submission

Name View Source Status
0001437749-18-018287-index-headers.html Edgar Link pending
0001437749-18-018287-index.html Edgar Link pending
0001437749-18-018287.txt Edgar Link pending
0001437749-18-018287-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvec-20180930.xml Edgar Link completed
nvec-20180930.xsd Edgar Link pending
nvec-20180930_cal.xml Edgar Link unprocessable
nvec-20180930_def.xml Edgar Link unprocessable
nvec-20180930_lab.xml Edgar Link unprocessable
nvec-20180930_pre.xml Edgar Link unprocessable
nvec20180930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending